1. Home
  2. NTRS vs DXCM Comparison

NTRS vs DXCM Comparison

Compare NTRS & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Northern Trust Corporation

NTRS

Northern Trust Corporation

SELL

Current Price

$162.63

Market Cap

32.6B

Sector

Finance

ML Signal

SELL

Logo DexCom Inc.

DXCM

DexCom Inc.

SELL

Current Price

$83.49

Market Cap

34.4B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
NTRS
DXCM
Founded
1889
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.6B
34.4B
IPO Year
2007
2005

Fundamental Metrics

Financial Performance
Metric
NTRS
DXCM
Price
$162.63
$83.49
Analyst Decision
Hold
Strong Buy
Analyst Count
16
29
Target Price
★ $181.71
$96.46
AVG Volume (30 Days)
944.0K
★ 3.7M
Earning Date
10-21-2026
10-29-2026
Dividend Yield
★ 2.10%
N/A
EPS Growth
N/A
★ 47.18
EPS
★ 2.71
1.15
Revenue
★ $8,086,400,000.00
N/A
Revenue This Year
$14.28
$12.17
Revenue Next Year
$2.38
$10.78
P/E Ratio
★ $61.80
$73.97
Revenue Growth
N/A
★ N/A
52 Week Low
$121.12
$54.11
52 Week High
$195.78
$92.59

Technical Indicators

Market Signals
Indicator
NTRS
DXCM
Relative Strength Index (RSI) 25.38 41.47
Support Level $158.98 $82.58
Resistance Level $172.36 $91.77
Average True Range (ATR) 2.93 2.02
MACD -0.37 -0.27
Stochastic Oscillator 19.13 13.02

Price Performance

Historical Comparison
NTRS
DXCM

About NTRS Northern Trust Corporation

Northern Trust is a leading provider of wealth management, asset servicing, asset management, and banking to corporations, institutions, affluent families, and individuals. Founded in Chicago in 1889, Northern Trust has offices in 20 states and Washington, D.C. as well as 23 locations in Canada, Europe, the Middle East, and Asia-Pacific. As of December 2025, Northern Trust had assets under custody or administration of $18.7 trillion and assets under management of $1.8 trillion.

About DXCM DexCom Inc.

DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.

Share on Social Networks: